Change in QRS area by cardiac resynchronization therapy is associated with clinical outcomes and echocardiographic response

Back

ESC Premium Access

Change in QRS area by cardiac resynchronization therapy is associated with clinical outcomes and echocardiographic response

Session: Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up

Topic: Cardiac Resynchronisation Therapy (CRT)

Speaker: Mr M. Ghossein (Maastricht, NL)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Mr Mohammed Ali Ghossein

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

0 follower

7 more presentations in this session

Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator

Speaker: Doctor V. Waldmann (Paris, FR)

Risk factors for mortality within one-year after implantable cardioverter defibrillator implantation: a nationwide study

Speaker: Miss A. Alhakak (Copenhagen, DK)

Relationship between mortality after ICD implantation and center volume in Belgium

Speaker: Mr R. Hoffmann (Leuven, BE)

Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study

Speaker: Miss A. Alhakak (Copenhagen, DK)

Automated screening tool for Subcutaneous Implantable Defibrillator in Brugada syndrome has a high eligibility rate which is predicted by simple electrocardiographic parameters

Speaker: Mr S. Marelli (Pavia, IT)

Access the full session

Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up

Speakers: Mr M. Ghossein, Doctor V. Waldmann, Miss A. Alhakak, Mr R. Hoffmann, Miss A. Alhakak...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Change in QRS area by cardiac resynchronization therapy is associated with clinical outcomes and echocardiographic response

About the speaker

Mr Mohammed Ali Ghossein

7 more presentations in this session

Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator

Risk factors for mortality within one-year after implantable cardioverter defibrillator implantation: a nationwide study

Relationship between mortality after ICD implantation and center volume in Belgium

Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study

Automated screening tool for Subcutaneous Implantable Defibrillator in Brugada syndrome has a high eligibility rate which is predicted by simple electrocardiographic parameters

Access the full session

Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up

About the event

ESC Congress 2020

ESC 365 is supported by